AI improves accuracy in identifying rare kidney cancer, but physicians also become more likely to accept incorrect advice
A pathology interpretation study involving 21 physicians shows AI’s potential to help identify rare kidney cancer, while revealing the cost of trust: those who benefit more from correct advice may also be more likely to follow incorrect advice.